請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/72554
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 蔡文友(Wen-Yu Tsai) | |
dc.contributor.author | Yi-Ching Tung | en |
dc.contributor.author | 童怡靖 | zh_TW |
dc.date.accessioned | 2021-06-17T07:00:48Z | - |
dc.date.available | 2020-08-26 | |
dc.date.copyright | 2019-08-26 | |
dc.date.issued | 2019 | |
dc.date.submitted | 2019-08-02 | |
dc.identifier.citation | Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR, Yu L, Miao D, Erlich HA, Fain PR, Barriga KJ, Norris JM, Rewers MJ, and Eisenbarth GS. Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci U S A. 2006; 103(38): 14074-9.
American Diabetes Association. Summary of revisions for the 2010 Clinical Practice Recommendations. Diabetes Care. 2010; 33 Suppl 1: S3. American Diabetes Assciation. Type 2 diabetes in children and adolescents.. Pediatrics. 2000; 105(3 Pt 1): 671-80 Andrade AC, Jee YH, and Nilsson O. New Genetic Diagnoses of Short Stature Provide Insights into Local Regulation of Childhood Growth. Horm Res Paediatr. 2017; 88(1): 22-37. Arnqvist HJ, Littorin B, Nystrom L, Schersten B, Ostman J, Blohme G, Lithner F, and Wibell L. Difficulties in classifying diabetes at presentation in the young adult. Diabet Med. 1993; 10(7): 606-13. Ashcroft FM, and Rorsman P. Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol. 1989; 54(2): 87-143. Atkinson MA, and Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001; 358(9277): 221-9. Audi L, Ahmed SF, Krone N, Cools M, McElreavey K, Holterhus PM, Greenfield A, Bashamboo A, Hiort O, Wudy SA, McGowan R, and The EUCA. GENETICS IN ENDOCRINOLOGY: Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 'DSDnet'. Eur J Endocrinol. 2018; 179(4): R197-R206. Bach JF. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev. 1994; 15(4): 516-42. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, and De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990; 347(6289): 151-6. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, and Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med. 1990; 322(26): 1836-41. Baker PR II, and Steck AK. The past, present, and future of genetic associations in type 1 diabetes. Curr Diab Rep. 2011; 11(5): 445-53. Ballabio A, Bardoni B, Carrozzo R, Andria G, Bick D, Campbell L, Hamel B, Ferguson-Smith MA, Gimelli G, Fraccaro M, and et al. Contiguous gene syndromes due to deletions in the distal short arm of the human X chromosome. Proc Natl Acad Sci U S A. 1989; 86(24): 10001-5. Baron J, Savendahl L, De Luca F, Dauber A, Phillip M, Wit JM, and Nilsson O. Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol. 2015; 11(12): 735-46. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, Julier C, Morahan G, Nerup J, Nierras C, Plagnol V, Pociot F, Schuilenburg H, Smyth DJ, Stevens H, Todd JA, Walker NM, Rich SS, and Type 1 Diabetes Genetics C. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009; 41(6): 703-7. Baschal EE, and Eisenbarth GS. Extreme genetic risk for type 1A diabetes in the post-genome era. J Autoimmun. 2008; 31(1): 1-6. Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, Vekemans M, Le Merrer M, Munnich A, and Cormier-Daire V. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet. 1998; 19(1): 67-9. Bentley G, Higuchi R, Hoglund B, Goodridge D, Sayer D, Trachtenberg EA, and Erlich HA. High-resolution, high-throughput HLA genotyping by next-generation sequencing. Tissue Antigens. 2009; 74(5): 393-403. Berger B, Stenstrom G, and Sundkvist G. Random C-peptide in the classification of diabetes. Scand J Clin Lab Invest. 2000; 60(8): 687-93. Bergholdt R, Brorsson C, Palleja A, Berchtold LA, Floyel T, Bang-Berthelsen CH, Frederiksen KS, Jensen LJ, Storling J, and Pociot F. Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes. 2012; 61(4): 954-62. Beyan H, Wen L, and Leslie RD. Guts, germs, and meals: the origin of type 1 diabetes. Curr Diab Rep. 2012; 12(5): 456-62. Bilbao JR, Rica I, Vazquez JA, Busturia MA, and Castano L. Influence of sex and age at onset on autoantibodies against insulin, GAD65 and IA2 in recent onset type 1 diabetic patients. Horm Res. 2000; 54(4): 181-5. Binder G. Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr. 2011; 75(2): 81-9. Binder G, Ranke MB, and Martin DD. Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature. J Clin Endocrinol Metab. 2003; 88(10): 4891-6. Bingley PJ, Bonifacio E, and Mueller PW. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes. 2003; 52(5): 1128-36. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, and Gale EA. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes. 1997; 46(11): 1701-10. Blum WF, Ross JL, Zimmermann AG, Quigley CA, Child CJ, Kalifa G, Deal C, Drop SL, Rappold G, and Cutler GB, Jr. GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial. J Clin Endocrinol Metab. 2013; 98(8): E1383-92. Borchers AT, Uibo R, and Gershwin ME. The geoepidemiology of type 1 diabetes. Autoimmun Rev. 2010; 9(5): A355-65. Castillo MJ, Scheen AJ, and Lefebvre PJ. Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1995; 80(2): 393-9. Chang P, Tsai WY, Hou JW, Hsiao PH, and Lee JS. Autoimmune thyroiditis in children with Turner syndrome. J Formos Med Assoc. 2000; 99(11): 823-6. Chang YH, Shiau MY, Tsai ST, and Lan MS. Autoantibodies against IA-2, GAD, and topoisomerase II in type 1 diabetic patients. Biochem Biophys Res Commun. 2004; 320(3): 802-9. Chen BH, Chung SB, Chiang W, and Chao MC. GAD65 antibody prevalence and association with thyroid antibodies, HLA-DR in Chinese children with type 1 diabetes mellitus. Diabetes Res Clin Pract. 2001; 54(1): 27-32. Chen J, Wildhardt G, Zhong Z, Roth R, Weiss B, Steinberger D, Decker J, Blum WF, and Rappold G. Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain. J Med Genet. 2009; 46(12): 834-9. Chen PL, Fann CS, Chu CC, Chang CC, Chang SW, Hsieh HY, Lin M, Yang WS, and Chang TC. Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles. PLoS One. 2011; 6(1): e16635. Chen YC, Tung YC, Liu SY, Lee CT, and Tsai WY. Clinical characteristics of type 1 diabetes mellitus in Taiwanese children aged younger than 6 years: A single-center experience. J Formos Med Assoc. 2017; 116(5): 340-4. Chien MW, Fu SH, Hsu CY, Liu YW, and Sytwu HK. The Modulatory Roles of N-glycans in T-Cell-Mediated Autoimmune Diseases. Int J Mol Sci. 2018; 19(3). Chuang LM, Wu HP, Tsai WY, Lin BJ, and Tai TY. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families. Diabetes Care. 1995; 18(11): 1483-6. Corradin O, Saiakhova A, Akhtar-Zaidi B, Myeroff L, Willis J, Cowper-Sal lari R, Lupien M, Markowitz S, and Scacheri PC. Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res. 2014; 24(1): 1-13. Dauber A, Yu Y, Turchin MC, Chiang CW, Meng YA, Demerath EW, Patel SR, Rich SS, Rotter JI, Schreiner PJ, Wilson JG, Shen Y, Wu BL, and Hirschhorn JN. Genome-wide association of copy-number variation reveals an association between short stature and the presence of low-frequency genomic deletions. Am J Hum Genet. 2011; 89(6): 751-9. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SC, Jenkins SC, Palmer SM, and et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 1994; 371(6493): 130-6. de Goffau MC, Luopajarvi K, Knip M, Ilonen J, Ruohtula T, Harkonen T, Orivuori L, Hakala S, Welling GW, Harmsen HJ, and Vaarala O. Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes. 2013; 62(4): 1238-44. de Magalhaes JP, Finch CE, and Janssens G. Next-generation sequencing in aging research: emerging applications, problems, pitfalls and possible solutions. Ageing Res Rev. 2010; 9(3): 315-23. Decochez K, Keymeulen B, Somers G, Dorchy H, De Leeuw IH, Mathieu C, Rottiers R, Winnock F, ver Elst K, Weets I, Kaufman L, Pipeleers DG, Gorus FK, and Belgian Diabetes R. Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry. Diabetes Care. 2000; 23(8): 1072-8. Diabetes Association of The Republic Of China, Taiwan. Executive summary of the DAROC clinical practice guidelines for diabetes care- 2018. J Formos Med Assoc 2019 Apr. Durand C, and Rappold GA. Height matters-from monogenic disorders to normal variation. Nat Rev Endocrinol. 2013; 9(3): 171-7. Durand C, Roeth R, Dweep H, Vlatkovic I, Decker E, Schneider KU, and Rappold G. Alternative splicing and nonsense-mediated RNA decay contribute to the regulation of SHOX expression. PLoS One. 2011; 6(3): e18115. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med. 1986; 314(21): 1360-8. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P, and Type 1 Diabetes Genetics C. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes. 2008; 57(4): 1084-92. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2000; 23 Suppl 1: S4-19. Faber OK, and Binder C. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Diabetes. 1977; 26(7): 605-10. Feeney SJ, Myers MA, Mackay IR, Zimmet PZ, Howard N, Verge CF, and Rowley MJ. Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM. Diabetes Care. 1997; 20(9): 1403-7. Fernandez IC, Del Carmen Camberos M, Passicot GA, Martucci LC, and Cresto JC. Children at risk of diabetes type 1. Treatment with acetyl-L-carnitine plus nicotinamide - case reports. J Pediatr Endocrinol Metab. 2013; 26(3-4): 347-55. Floyel T, Kaur S, and Pociot F. Genes affecting beta-cell function in type 1 diabetes. Curr Diab Rep. 2015; 15(11): 97. Ford CE, Jones KW, Polani PE, De Almeida JC, and Briggs JH. A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome). Lancet. 1959; 1(7075): 711-3. Fourlanos S, Varney MD, Tait BD, Morahan G, Honeyman MC, Colman PG, and Harrison LC. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care. 2008; 31(8): 1546-9. Fukami M, Seki A, and Ogata T. SHOX Haploinsufficiency as a Cause of Syndromic and Nonsyndromic Short Stature. Mol Syndromol. 2016; 7(1): 3-11. Gatta V, Antonucci I, Morizio E, Palka C, Fischetto R, Mokini V, Tumini S, Calabrese G, and Stuppia L. Identification and characterization of different SHOX gene deletions in patients with Leri-Weill dyschondrosteosys by MLPA assay. J Hum Genet. 2007; 52(1): 21-7. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965; 14(10): 619-33. Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, and Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab. 2005; 90(8): 4904-11. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, and Pipeleers DG. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia. 1997; 40(1): 95-9. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM, Schaefer JB, Zarghami M, Day HL, Landin-Olsson M, Palmer JP, Janer-Villanueva M, Hood L, Sundkvist G, Lernmark A, Breslow N, Dahlquist G, Blohme G, Diabetes Incidence in Sweden Study G, and Swedish Childhood Diabetes Study G. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes. 2002; 51(5): 1346-55. Gravholt CH, Andersen NH, and Conway GS. Clinical Practice Guidelines for the Care of Girls and Women With Turner Syndrome. Pediatrics. 2017; 140(5). Group DP. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet Med. 2006; 23(8): 857-66. Guo Z, Hood L, and Petersdorf EW. Oligonucleotide arrays for high resolution HLA typing. Rev Immunogenet. 1999; 1(2): 220-30. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, and Lernmark A. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest. 1995; 95(4): 1505-11. Hanley JA, and McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143(1): 29-36. Helena Mangs A, and Morris BJ. The Human Pseudoautosomal Region (PAR): Origin, Function and Future. Curr Genomics. 2007; 8(2): 129-36. Helmberg W, Dunivin R, and Feolo M. The sequencing-based typing tool of dbMHC: typing highly polymorphic gene sequences. Nucleic Acids Res. 2004; 32(Web Server issue): W173-5. Hirschhorn JN. Genetic epidemiology of type 1 diabetes. Pediatr Diabetes. 2003; 4(2): 87-100. Hober D, and Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol. 2010; 6(5): 279-89. Hoeldtke RD, Bryner KD, Horvath GG, Byerly MR, Hobbs GR, Marcovina SM, and Lernmark A. Antibodies to GAD and glycemic control in recent-onset IDDM. Diabetes Care. 1997; 20(12): 1900-3. Hooper LV, Littman DR, and Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012; 336(6086): 1268-73. Hou T, Macmillan H, Chen Z, Keech CL, Jin X, Sidney J, Strohman M, Yoon T, and Mellins ED. An insertion mutant in DQA1*0501 restores susceptibility to HLA-DM: implications for disease associations. J Immunol. 2011; 187(5): 2442-52. Hsu PY, Tung YC, Tsai WY, Lee JS, and Hsiao PH. Effect of growth hormone therapy on adult height of children with Turner syndrome. J Formos Med Assoc. 2008; 107(9): 704-9. Hu G, Fan Y, Wang L, Yao RE, Huang X, Shen Y, Yu Y, and Gu X. Copy number variations in 119 Chinese children with idiopathic short stature identified by the custom genome-wide microarray. Mol Cytogenet. 2016; 9: 16. Huang HS, Peng JT, She JY, Zhang LP, Chao CC, Liu KH, and She JX. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population. Hum Immunol. 1995; 44(4): 210-9. Huber C, Cusin V, Le Merrer M, Mathieu M, Sulmont V, Dagoneau N, Munnich A, and Cormier-Daire V. SHOX point mutations in dyschondrosteosis. J Med Genet. 2001; 38(5): 323. Huber C, Rosilio M, Munnich A, Cormier-Daire V, and French SGM. High incidence of SHOX anomalies in individuals with short stature. J Med Genet. 2006; 43(9): 735-9. Ilonen J, Kiviniemi M, Lempainen J, Simell O, Toppari J, Veijola R, Knip M, and Finnish Pediatric Diabetes R. Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity. Pediatr Diabetes. 2016; 17 Suppl 22: 8-16. Izpisua-Belmonte JC, and Duboule D. Homeobox genes and pattern formation in the vertebrate limb. Dev Biol. 1992; 152(1): 26-36. Jensen ET, and Dabelea D. Type 2 Diabetes in Youth: New Lessons from the SEARCH Study. Curr Diab Rep. 2018; 18(6): 36. Jiang YD, Chang CH, Tai TY, Chen JF, and Chuang LM. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database. J Formos Med Assoc. 2012; 111(11): 599-604. Kang MJ. Novel genetic cause of idiopathic short stature. Ann Pediatr Endocrinol Metab. 2017; 22(3): 153-7. Kaprio J, Tuomilehto J, Koskenvuo M, Romanov K, Reunanen A, Eriksson J, Stengard J, and Kesaniemi YA. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia. 1992; 35(11): 1060-7. Katahira M, Ishiguro T, Segawa S, Kuzuya-Nagao K, Hara I, and Nishisaki T. Reevaluation of human leukocyte antigen DR-DQ haplotype and genotype in type 1 diabetes in the Japanese population. Horm Res. 2008; 69(5): 284-9. Katahira M, Maeda H, Tosaki T, and Segawa S. The human leukocyte antigen class II gene has different contributions to autoimmune type 1 diabetes with or without autoimmune thyroid disease in the Japanese population. Diabetes Res Clin Pract. 2009; 85(3): 293-7. Kawasaki A, Ito I, Hikami K, Ohashi J, Hayashi T, Goto D, Matsumoto I, Ito S, Tsutsumi A, Koga M, Arinami T, Graham RR, Hom G, Takasaki Y, Hashimoto H, Behrens TW, Sumida T, and Tsuchiya N. Role of STAT4 polymorphisms in systemic lupus erythematosus in a Japanese population: a case-control association study of the STAT1-STAT4 region. Arthritis Res Ther. 2008; 10(5): R113. Kawasaki E, Matsuura N, and Eguchi K. Type 1 diabetes in Japan. Diabetologia. 2006; 49(5): 828-36. Kepka A, Chojnowska S, Okungbowa OE, and Zwierz K. The role of carnitine in the perinatal period. Dev Period Med. 2014; 18(4): 417-25. Kimpimaki T, Kulmala P, Savola K, Kupila A, Korhonen S, Simell T, Ilonen J, Simell O, and Knip M. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab. 2002; 87(10): 4572-9. Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, and Akerblom HK. Environmental triggers and determinants of type 1 diabetes. Diabetes. 2005; 54 Suppl 2: S125-36. Koeleman BP, Lie BA, Undlien DE, Dudbridge F, Thorsby E, de Vries RR, Cucca F, Roep BO, Giphart MJ, and Todd JA. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun. 2004; 5(5): 381-8. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, Angenent LT, and Ley RE. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A. 2011; 108 Suppl 1: 4578-85. Kordonouri O, Hartmann R, Charpentier N, Knip M, Danne T, and Ilonen J. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany. Exp Clin Endocrinol Diabetes. 2010; 118(4): 245-9. Kosho T, Muroya K, Nagai T, Fujimoto M, Yokoya S, Sakamoto H, Hirano T, Terasaki H, Ohashi H, Nishimura G, Sato S, Matsuo N, and Ogata T. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab. 1999; 84(12): 4613-21. Kozhemyakina E, Lassar AB, and Zelzer E. A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development. 2015; 142(5): 817-31. Kumar, Robbins, and Cotran. Diseases of immunity. Pathologic Basis of Disease, 7th ed. Chapter 6, p. 203. Kyvik KO, Green A, and Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ. 1995; 311(7010): 913-7. Lan MS, Wasserfall C, Maclaren NK, and Notkins AL. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1996; 93(13): 6367-70. Langer LO, Jr. Dyschondrosteosis, a Hereditable Bone Dysplasia with Characteristic Roentgenographic Features. Am J Roentgenol Radium Ther Nucl Med. 1965; 95: 178-88. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, Ferreira T, Wood AR, Weyant RJ, Segre AV, Speliotes EK, Wheeler E, Soranzo N, Park JH, Yang J, Gudbjartsson D, Heard-Costa NL, Randall JC, Qi L, Vernon Smith A, Magi R, Pastinen T, Liang L, Heid IM, Luan J, Thorleifsson G, Winkler TW, Goddard ME, Sin Lo K, Palmer C, Workalemahu T, Aulchenko YS, Johansson A, Zillikens MC, Feitosa MF, Esko T, Johnson T, Ketkar S, Kraft P, Mangino M, Prokopenko I, Absher D, Albrecht E, Ernst F, Glazer NL, Hayward C, Hottenga JJ, Jacobs KB, Knowles JW, Kutalik Z, Monda KL, Polasek O, Preuss M, Rayner NW, Robertson NR, Steinthorsdottir V, Tyrer JP, Voight BF, Wiklund F, Xu J, Zhao JH, Nyholt DR, Pellikka N, Perola M, Perry JR, Surakka I, Tammesoo ML, Altmaier EL, Amin N, Aspelund T, Bhangale T, Boucher G, Chasman DI, Chen C, Coin L, Cooper MN, Dixon AL, Gibson Q, Grundberg E, Hao K, Juhani Junttila M, Kaplan LM, Kettunen J, Konig IR, Kwan T, Lawrence RW, Levinson DF, Lorentzon M, McKnight B, Morris AP, Muller M, Suh Ngwa J, Purcell S, Rafelt S, Salem RM, Salvi E, Sanna S, Shi J, Sovio U, Thompson JR, Turchin MC, Vandenput L, Verlaan DJ, Vitart V, White CC, Ziegler A, Almgren P, Balmforth AJ, Campbell H, Citterio L, De Grandi A, Dominiczak A, Duan J, Elliott P, Elosua R, Eriksson JG, Freimer NB, Geus EJ, Glorioso N, Haiqing S, Hartikainen AL, Havulinna AS, Hicks AA, Hui J, Igl W, Illig T, Jula A, Kajantie E, Kilpelainen TO, Koiranen M, Kolcic I, Koskinen S, Kovacs P, Laitinen J, Liu J, Lokki ML, Marusic A, Maschio A, Meitinger T, Mulas A, Pare G, Parker AN, Peden JF, Petersmann A, Pichler I, Pietilainen KH, Pouta A, Ridderstrale M, Rotter JI, Sambrook JG, Sanders AR, Schmidt CO, Sinisalo J, Smit JH, Stringham HM, Bragi Walters G, Widen E, Wild SH, Willemsen G, Zagato L, Zgaga L, Zitting P, Alavere H, Farrall M, McArdle WL, Nelis M, Peters MJ, Ripatti S, van Meurs JB, Aben KK, Ardlie KG, Beckmann JS, Beilby JP, Bergman RN, Bergmann S, Collins FS, Cusi D, den Heijer M, Eiriksdottir G, Gejman PV, Hall AS, Hamsten A, Huikuri HV, Iribarren C, Kahonen M, Kaprio J, Kathiresan S, Kiemeney L, Kocher T, Launer LJ, Lehtimaki T, Melander O, Mosley TH, Jr., Musk AW, Nieminen MS, O'Donnell CJ, Ohlsson C, Oostra B, Palmer LJ, Raitakari O, Ridker PM, Rioux JD, Rissanen A, Rivolta C, Schunkert H, Shuldiner AR, Siscovick DS, Stumvoll M, Tonjes A, Tuomilehto J, van Ommen GJ, Viikari J, Heath AC, Martin NG, Montgomery GW, Province MA, Kayser M, Arnold AM, Atwood LD, Boerwinkle E, Chanock SJ, Deloukas P, Gieger C, Gronberg H, Hall P, Hattersley AT, Hengstenberg C, Hoffman W, Lathrop GM, Salomaa V, Schreiber S, Uda M, Waterworth D, Wright AF, Assimes TL, Barroso I, Hofman A, Mohlke KL, Boomsma DI, Caulfield MJ, Cupples LA, Erdmann J, Fox CS, Gudnason V, Gyllensten U, Harris TB, Hayes RB, Jarvelin MR, Mooser V, Munroe PB, Ouwehand WH, Penninx BW, Pramstaller PP, Quertermous T, Rudan I, Samani NJ, Spector TD, Volzke H, Watkins H, Wilson JF, Groop LC, Haritunians T, Hu FB, Kaplan RC, Metspalu A, North KE, Schlessinger D, Wareham NJ, Hunter DJ, O'Connell JR, Strachan DP, Wichmann HE, Borecki IB, van Duijn CM, Schadt EE, Thorsteinsdottir U, Peltonen L, Uitterlinden AG, Visscher PM, Chatterjee N, Loos RJ, Boehnke M, McCarthy MI, Ingelsson E, Lindgren CM, Abecasis GR, Stefansson K, Frayling TM, and Hirschhorn JN. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature. 2010; 467(7317): 832-8. Leka SK, Kitsiou-Tzeli S, Kalpini-Mavrou A, and Kanavakis E. Short stature and dysmorphology associated with defects in the SHOX gene. Hormones (Athens). 2006; 5(2): 107-18. Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP, Bolgiano D, Rodriguez L, Rajan A, Lernmark A, and Balasubramanyam A. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab. 2003; 88(11): 5090-8. Marchini A, Ogata T, and Rappold GA. A Track Record on SHOX: From Basic Research to Complex Models and Therapy. Endocr Rev. 2016; 37(4): 417-48. Marchini A, Rappold G, and Schneider KU. SHOX at a glance: from gene to protein. Arch Physiol Biochem. 2007; 113(3): 116-23. Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Fernandez-Vina M, Geraghty DE, Holdsworth R, Hurley CK, Lau M, Lee KW, Mach B, Maiers M, Mayr WR, Muller CR, Parham P, Petersdorf EW, Sasazuki T, Strominger JL, Svejgaard A, Terasaki PI, Tiercy JM, and Trowsdale J. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010; 75(4): 291-455. Menser MA, Forrest JM, and Bransby RD. Rubella infection and diabetes mellitus. Lancet. 1978; 1(8055): 57-60. Middleton D, Menchaca L, Rood H, and Komerofsky R. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens. 2003; 61(5): 403-7. Neufeld SJ, Wang F, and Cobb J. Genetic interactions between Shox2 and Hox genes during the regional growth and development of the mouse limb. Genetics. 2014; 198(3): 1117-26. Ng WY, Lee YS, Todd AL, Lui KF, Loke KY, and Thai AC. Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: a study of Chinese patients with diabetes mellitus. Autoimmunity. 2002; 35(2): 119-24. Noble JA, and Valdes AM. Genetics of the HLA region in the prediction of type 1 diabetes. Curr Diab Rep. 2011; 11(6): 533-42. Noble JA, Valdes AM, Varney MD, Carlson JA, Moonsamy P, Fear AL, Lane JA, Lavant E, Rappner R, Louey A, Concannon P, Mychaleckyj JC, Erlich HA, and Type 1 Diabetes Genetics C. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes. 2010; 59(11): 2972-9. Oliveira CS, and Alves C. The role of the SHOX gene in the pathophysiology of Turner syndrome. Endocrinol Nutr. 2011; 58(8): 433-42. Palmer JP. Insulin autoantibodies: their role in the pathogenesis of IDDM. Diabetes Metab Rev. 1987; 3(4): 1005-15. Pan WH, Fann CS, Wu JY, Hung YT, Ho MS, Tai TH, Chen YJ, Liao CJ, Yang ML, Cheng AT, and Chen YT. Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered. 2006; 61(1): 27-30. Park Y. Why is type 1 diabetes uncommon in Asia? Ann N Y Acad Sci. 2006; 1079: 31-40. Park Y, and Eisenbarth GS. Genetic susceptibility factors of Type 1 diabetes in Asians. Diabetes Metab Res Rev. 2001; 17(1): 2-11. Park Y, Lee H, Takino H, Abiru N, Kawasaki E, and Eisenbarth GS. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients. Acta Diabetol. 2001; 38(1): 51-6. Park Y, She JX, Wang CY, Lee H, Babu S, Erlich HA, Noble JA, and Eisenbarth GS. Common susceptibility and transmission pattern of human leukocyte antigen DRB1-DQB1 haplotypes to Korean and Caucasian patients with type 1 diabetes. J Clin Endocrinol Metab. 2000; 85(12): 4538-42. Park YS, Wang CY, Ko KW, Yang SW, Park M, Yang MC, and She JX. Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans. Hum Immunol. 1998; 59(12): 794-801. Paschou SA, Papadopoulou-Marketou N, Chrousos GP, and Kanaka-Gantenbein C. On type 1 diabetes mellitus pathogenesis. Endocr Connect. 2018; 7(1): R38-R46. Paschou SA, Petsiou A, Chatzigianni K, Tsatsoulis A, and Papadopoulos GK. Type 1 diabetes as an autoimmune disease: the evidence. Diabetologia. 2014; 57(7): 1500-1. Petersen JS, Dyrberg T, Karlsen AE, Molvig J, Michelsen B, Nerup J, and Mandrup-Poulsen T. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group. Diabetes. 1994; 43(11): 1291-6. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, and Shulman GI. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003; 300(5622): 1140-2. Pinsker JE. Clinical review: Turner syndrome: updating the paradigm of clinical care. J Clin Endocrinol Metab. 2012; 97(6): E994-1003. Plotnick L, Attie KM, Blethen SL, and Sy JP. Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience. Pediatrics. 1998; 102(2 Pt 3): 479-81. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, and Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81(3): 559-75. Ranke MB. Towards a consensus on the definition of idiopathic short stature. Horm Res. 1996; 45 Suppl 2: 64-6. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, Muroya K, Binder G, Kirsch S, Winkelmann M, Nordsiek G, Heinrich U, Breuning MH, Ranke MB, Rosenthal A, Ogata T, and Rappold GA. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet. 1997; 16(1): 54-63. Rappold G, Blum WF, Shavrikova EP, Crowe BJ, Roeth R, Quigley CA, Ross JL, and Niesler B. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet. 2007; 44(5): 306-13. Rappold GA, Fukami M, Niesler B, Schiller S, Zumkeller W, Bettendorf M, Heinrich U, Vlachopapadoupoulou E, Reinehr T, Onigata K, and Ogata T. Deletions of the homeobox gene SHOX (short stature homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab. 2002; 87(3): 1402-6. Rassi DM, Junta CM, Fachin AL, Sandrin-Garcia P, Mello SS, Fernandes AP, Deghaide NN, Foss-Freitas MC, Foss MC, Sakamoto-Hojo ET, Passos GA, and Donadi EA. Is HLA class II profile relevant for the study of large-scale differentially expressed genes in type 1 diabetes mellitus patients? Ann N Y Acad Sci. 2006; 1079: 305-9. Rendine S, Ferrero NM, Sacchi N, Costa C, Pollichieni S, and Amoroso A. Estimation of human leukocyte antigen class I and class II high-resolution allele and haplotype frequencies in the Italian population and comparison with other European populations. Hum Immunol. 2012; 73(4): 399-404. Rewers M, et al. Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes Epidemiology Research International Group. Diabetes. 1988; 37(8): 1113-9. Rich SS, Akolkar B, Concannon P, Erlich H, Hilner JE, Julier C, Morahan G, Nerup J, Nierras C, Pociot F, and Todd JA. Overview of the Type I Diabetes Genetics Consortium. Genes Immun. 2009; 10 Suppl 1: S1-4. Roark CL, Anderson KM, Simon LJ, Schuyler RP, Aubrey MT, and Freed BM. Multiple HLA epitopes contribute to type 1 diabetes susceptibility. Diabetes. 2014; 63(1): 323-31. Rosello-Diez A, and Joyner AL. Regulation of Long Bone Growth in Vertebrates; It Is Time to Catch Up. Endocr Rev. 2015; 36(6): 646-80. Rosilio M, Huber-Lequesne C, Sapin H, Carel JC, Blum WF, and Cormier-Daire V. Genotypes and phenotypes of children with SHOX deficiency in France. J Clin Endocrinol Metab. 2012; 97(7): E1257-65. Ross JL, Scott C, Jr., Marttila P, Kowal K, Nass A, Papenhausen P, Abboudi J, Osterman L, Kushner H, Carter P, Ezaki M, Elder F, Wei F, Chen H, and Zinn AR. Phenotypes Associated with SHOX Deficiency. J Clin Endocrinol Metab. 2001; 86(12): 5674-80. Sabbah E, Savola K, Kul | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/72554 | - |
dc.description.abstract | 遺傳疾病指的是由於基因的錯誤,導致疾病的產生。在內分泌疾病領域,我們各以單基因疾病的身材矮小及多基因疾病的第1型糖尿病,作為遺傳醫學在兒童內分泌疾病研究的探討模式。
在單基因身材矮小的部分,選擇了SHOX基因缺乏症,因為該基因於1997年發現後,病患給予生長激素治療有較好的身高預後。我們將診斷為特發性矮小(idiopathic short stature)及不成比例的身材矮小的病童,根據修改自Rappold的表現型評分系統大於7分的病患,進一步進行SHOX基因檢驗。病患抽取的DNA,進行多重連線探針擴增技術MLPA偵測基因缺失等拷貝數變異,未發現基因拷貝數病變的檢體,我們進行第二階段定序檢查SHOX基因及其調控區域。由於SHOX基因與肢體中段骨骼以及生長板軟骨內骨化(endochondral ossification)調控有關,所以病患前臂及手部腕關節可能是檢視的重要關鍵。我們的研究加入表現型評分系統,SHOX基因缺乏症檢出率為26%,病患都符合手臂跨度與身高的比值小於96.5%的標準,且均有前臂明顯短小的特徵,這將是臨床醫師懷疑該疾病的重點之一。腕骨影像上,包括遠端橈骨透亮化(radiolucency),骨骺三角化(triangularization),以及腕骨錐狀化(pyramidalization),尺骨錯位(Madelung deformity)皆為強烈懷疑該疾病的特徵。基因檢驗方面,我們的SHOX基因缺乏症病患中86%是由於不等大小的基因缺失,其中16%僅發生在調節增強區域,也僅有一位是點突變造成。由於該基因位於偽體染色體區域(PAR),當缺失片段較大時,可能會發生連續基因缺失症候群(contiguous gene deletion syndrome),甚至跨越PAR及一般性染色體基因區域,可能影響的基因可能有不同的遺傳模式。SHOX基因缺乏症是我們研究身材矮小的第一個候選基因,希望了解台灣SHOX基因缺乏症病患的基因表現型及遺傳模式,以作為後續身材矮小病患基因檢查的依據。 在多基因疾病中,則選擇自體免疫破壞的第1型糖尿病,其致病原因包括先天的遺傳基因,加上後天環境,包括飲食習慣,感染,化學物質等的誘發,使得免疫細胞攻擊β細胞,終究導致剩餘胰島素功能嚴重不足,甚至發生高血糖危症之酮酸中毒症。我們希望先由剩餘胰島素功能及胰島相關自體抗體的研究,界定第1型糖尿病患的正確診斷,進一步研究基因部分的影響。根據之前國外的研究,HLA基因占了遺傳影響的大部分,我們先進行第1型糖尿病HLA基因在台灣第1型糖尿病的風險性的研究。將104為第1型糖尿病病患,抽取白血球的分析,在HLA-A、-B、-C、-DRB1、-DQB1及 -DPB1定序分型法(sequence-based typing)分析其HLA基因型,並與504位對照組加以比較分析。23個對偶基因中在第1型糖尿病的病患組和對照組在下列四種檢定上(Armitage trend test,the allelic test,the genotypic test以及and the dominant model)有顯著上的差異,並以連鎖不平衡檢定發現三個易罹病的基因型DR3 (DRB1*03:01-DQB1*02:01),DR4 (DRB1*04:05-DQB1*04:01)及DR9 (DRB1*09:01-DQB1*03:03),與一個保護性基因型(DRB1*08:03-DQB1*06:01),該保護型單套型與自體免疫第1型糖尿病的關聯,為第一次發現。另外DQB1*03:02本身就是一個常見的易感基因,而DQB1*03:01則具有相當的保護性。這些資訊對於台灣本土第1型糖尿病研究相當重要。另外我們也發現DRB1*12:02對第1型糖尿病具有保護性,有趣的是我們之前在葛瑞夫氏症的研究DRB1*12:02也是一個保護的對偶基因。是否某些對偶基因可同時減少自體免疫過程的發生,更值得進一步研究探討。根據我們研究的結果,可以做為第1型糖尿病遺傳致病機轉研究的基石。在多基因疾病中,加上其他風險基因或是環境、飲食及感染、等分析,可以做為疾病預測模式的參考。 運用基因醫學的進步,不論是在單基因或多基因的兒童內分泌疾病,精準醫學能在診斷及治療有決定性的幫助。期待我們在身材矮小及糖尿病疾患建立的基因診斷模式,也能成為未來相關疾病研究的基石。 | zh_TW |
dc.description.abstract | A genetic disorder is a genetic problem caused by one or more abnormalities in the genome. A monogenic disorder is the result of a single mutated gene and multiple gene disorders are associated with the combination of the effects of multiple genes, epigenetic and environmental factors. We chose monogenic short stature and type 1 diabetes as interests of the study. We hope to demonstrate the application of genetic medicine in pediatric endocrine diseases.
A deficiency in the SHOX gene (short stature homeobox-containing gene) is a newly defined cause of short stature found in 1997. Growth hormone therapy is proved to use in such patients for the better height outcome. Twenty-three patients with idiopathic short stature or disproportionately short stature were enrolled in this study. The phenotype scoring system, modified from Rappold et al. was used for the selection of patients and patients with more than 7 points were screened for SHOX deficiency. A multiplex ligation-dependent probe amplification (MLPA) assay was used to identify the DNA copy number of SHOX gene and its regulatory regions. Sequencing of the SHOX gene was performed if no deletions were detected by MLPA. We found that SHOX gene deletion or mutation was detected in 26% of the disproportionately short children. All patients with SHOX deficiency had an arm-span-to-height ratio less than 96.5%, and a short forearm phenotype; these were the most striking features in patients with SHOX deficiency and it provides the clinicians to consider the SHOX gene mutation. The striking radiological findings of wrist joint include “lucency” of the distal radius, “triangularization” of the distal radial epiphysis and “Madelung deformity” attributed to premature epiphyseal fusion of the distal radius related to a disturbance in the programmed cell death of hypertrophic chondrocytes. Eighty-six percent of patients with SHOX deficiency in our study had a variable deletion size. One deletion (16%) was detected only in the regulatory enhancer region. Another patient had a missense mutation of the SHOX gene. Contiguous gene deletion syndrome involving the SHOX gene is not rare. SHOX gene is the first candidate gene in our study for monogenic short stature. Type 1 diabetes mellitus (T1D) is an autoimmune disease characterized by T-cell-mediated pancreatic β-cell destruction. The pathogenesis of T1D features a complex interaction of genetic, environmental, and immunological factors. In the genetic aspect, the HLA genes that encode molecules that bind and present peptide antigens to T-cells accounted for approximately half the genetic risk of T1D. We performed direct comprehensive genotyping of 6 classical HLA loci (HLA-A, -B, -C, -DPB1, -DQB1, and -DRB1) to 4-digit resolution in 104 unrelated T1D patients and 504 controls. Genomic DNA from these subjects were extracted and performed HLA sequence-based typing. Of these, 23 alleles exhibited frequency differences between T1D cases and controls in the Armitage trend test, the allelic test, the genotypic test and the dominant model. We analyzed the linkage disequilibrium (LD) between these 23 alleles and found three susceptibility haplotypes of DR3 (DRB1*03:01-DQB1*02:01), DR4 (DRB1*04:05-DQB1*04:01), and DR9 (DRB1*09:01-DQB1*03:03) and one protective haplotype (DRB1*08:03-DQB1*06:01). DRB1*08:03-DQB1*06:01 is the first report to associated with autoimmune type 1 diabetes. DQB1*03:02 was itself a susceptibility allele. The DRB1*12:02 in our study seems to protect against T1D. Intriguingly, in our previous study in patients with Graves’ disease, DRB1*12:02 was also identified as a protective allele. Maybe it implies that some alleles will protect from or exert the autoimmune process. Our study has yielded useful information on the combined effects of different HLA loci and alleles on T1D in Taiwan. In such multifactorial disorders, we might collect the data of environment exposures in addition to the genotypes of associated genes to establish the disease prediction model. Based on the genetic diagnosis, the health practitioners can make precision medicine in such pediatric endocrine disorders, including monogenic and multifactorial diseases. Our work in monogenic short stature and type 1 diabetes may be helpful clinically and could be a reference of genetic studies in the future. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T07:00:48Z (GMT). No. of bitstreams: 1 ntu-108-D93421006-1.pdf: 3398918 bytes, checksum: 2ead87431ab206f7d7e3cbcebbee0571 (MD5) Previous issue date: 2019 | en |
dc.description.tableofcontents | 目 錄
口試委員會審定書……………………………………………………………… i 誌謝………………………………………………………………………………. ii 中文摘要………………………………………………………………………… iii 英文摘要…………………………………………………………………………. vi 目錄………………………………………………………………………………. ix 圖表目錄…………………………………………………………………………. x 博士論文內容 第一章 緒論…………………………………………………………………… 1 第一部分 單基因身材矮小的研究:SHOX 基因缺乏症……….…….. 4 第二部分 多基因疾病的研究:第1型糖尿病……………………….… 10 第三部分 研究的目的與假說…………………………………………... 20 第二章 研究方法與材料……………………………………………………... 21 第三章 結果…………………………………………………………………... 33 第四章 討論……………………………………………………....................... 41 第五章 展望……………………………………………………....................... 60 第六章 論文英文簡述……………………………………………………....... 69 第七章 參考文獻……………………………………………………............... 93 第八章 圖表 ………………………………………………………………….. 112 第九章 附錄 ………………………………………………….......................... 147 圖 表 目 錄 表一、國際小兒內分泌診斷ICPED的生長遲緩分類…………………………113 表二、常見的胰島相關自體抗體………………………………………………..114 表三、SHOX基因缺乏症病人與非SHOX基因缺乏症矮小病患的比較….…115 表四、SHOX基因缺乏症病患的臨床資料及表型評分…………………….….116 表五、剩餘胰島素功能檢查研究中糖尿病病患及對照組的基本臨床資料…..117 表六、糖尿病病童及對照組六分鐘昇糖素檢查血清C-胜鏈胰島素結果….…118 表七、胰島相關自體抗體研究中第1型糖尿病病童的基本臨床資料…….….119 表八、剩餘胰島素功能與其他變數的多元線性回歸分析……………………120 表九、全面性HLA基因研究中第1型糖尿病患的基本臨床資料……………121 表十、第1型糖尿病患與對照組p值<0.05的12個易感的對偶基因………122 表十一、第1型糖尿病患與對照組p值<0.05的11個保護的對偶基因……..124 表十二、第1型糖尿病患與對照組無統計差別的對偶基因……………………..126 表十三、第1型糖尿病患與對照組的單套型的帶因率及勝算比……………..128 表十四、第1型糖尿病患與對照組單套易感基因型(DRB1-DQB1)的組合的相對危險性………….………….………….………….………….………….….…129 表十五、第1型糖尿病患有甲狀腺自體抗體與無抗體p值<0.05的5個保護的對偶基因………….………….………….………….………….………….….…130 表十六、在顯性遺傳模式下相關對偶基因及單套型的族群相差危險性………131 表十七、HLA基因分型檢驗方法優缺點比較圖………………………………...132 表十八、台灣第1型糖尿病易罹病及保護基因型與國外研究之比較…………133 圖一、單基因疾病身材矮小的研究設計…………………………………………134 圖二、多基因疾病第1型糖尿病的研究設計及假說……………………………135 圖三、SHOX基因缺乏症的臨床特徵……….………….………….………….…136 圖四、SHOX基因缺乏症的典型影像表現….………….………………………137 圖五、七位SHOX基因缺乏症患者的基因診斷……….…………………….….138 圖六、第1型糖尿病患及第2型糖尿病患空腹血清C-胜鏈胰島素數值…….139 圖七、第1型糖尿病患及第2型糖尿病患昇糖素刺激後六分鐘的血清中C-胜鏈胰島素數值……….………….…………………………………….………………140 圖八、台灣初診斷第1型糖尿病童胰島相關自體抗體的陽性率.……………141 圖九、第1型糖尿病患的連鎖不平衡分析HLA-C, -B, -DRB1, -DQB1及 -DPB1呈現明顯相關性……….…………………………………….………………….…142 圖十、根據邏輯回歸模型的第1型糖尿病接收者操作特徵曲線…………....143 圖十一、HLA基因與HLA分子結構…………………………………………..144 圖十二、 第1型糖尿病免疫相關基因與致病機轉…………………………...145 圖十三、第1型糖尿病的多種體學研究設計……………………………………146 | |
dc.language.iso | zh-TW | |
dc.title | 基因醫學在小兒內分泌疾病之應用 | zh_TW |
dc.title | The application of genetic medicine in pediatric endocrine diseases | en |
dc.type | Thesis | |
dc.date.schoolyear | 107-2 | |
dc.description.degree | 博士 | |
dc.contributor.coadvisor | 江伯倫(Bor-Luen Chiang) | |
dc.contributor.oralexamcommittee | 李燕晉(Yann-Jinn Lee),羅福松(Fu-Sung Lo),楊偉勛(Wei-Shiung Yang),陳沛隆(Pei-Lung Chen) | |
dc.subject.keyword | SHOX基因,多重連線探針擴增技術MLPA,第1型糖尿病,β細胞,HLA基因,單套型,連鎖不平衡, | zh_TW |
dc.subject.keyword | SHOX gene,multiplex ligation-dependent probe amplification (MLPA),type 1 diabetes (T1D),β cell,HLA gene,haplotype,linkage disequilibrium (LD), | en |
dc.relation.page | 148 | |
dc.identifier.doi | 10.6342/NTU201902417 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2019-08-02 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
顯示於系所單位: | 臨床醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-108-1.pdf 目前未授權公開取用 | 3.32 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。